Professor Carole Longson MBE appointed Chief Scientific Officer at the ABPI

The ABPI is delighted to announce the appointment of Professor Carole Longson MBE as Chief Scientific Officer at the Association of the British Pharmaceutical Industry (ABPI). Carole joins the ABPI from her current role as Executive Director and Board Member at the National Institute for Health and...

AMR Industry Alliance launches first report into Industry's AMR action globally

As the new AMR Industry Alliance launches its first progress report, ABPI chief executive Mike Thompson welcome the industry’s willingness to work collaboratively to detect, prevent and control AMR.

Preparing for Brexit: ABPI’s reaction to MHRA update for pharma

As the MHRA publishes an update to pharmaceutical companies on preparing for Brexit, the ABPI reaffirms the importance of patient and public health in negotiations.

ABPI response to the House of Lords Science and Technology Committee report

This week, the House of Lords Science and Technology Committee published a report into the Life Sciences Industrial Strategy, asking: "Who's Driving the Bus?"

Mike Thompson speech to the ABPI Annual Conference 2018

Mike Thompson, chief executive of the ABPI, opening address to the ABPI Annual Conference outlining the strength of the industry and looking ahead to the next 70 years.

Pharmaceutical industry continues to invest significantly in UK research and development

ABPI’s Disclosure UK shows the pharmaceutical industry continues to invest in UK R&D:

• overall R&D spend increases by 9.7% - HCPs commitment to transparency and disclosure shows no sign of waning
• GDPR contributes to reduction in numbers of individually named HCPs – down to an estimated 49.1% of...

Pharmaceutical industry responds to Trade Bill amendment on medicines

Parliament has voted in favour of amendment NC17 to the Trade Bill that will make it a negotiating objective for the UK Government to seek the UK's participation in the European medicines regulatory network.

Lisa Anson speech to the ABPI Annual Conference 2018

Lisa Anson, President of the ABPI, closing remarks to the ABPI Annual Conference on the future of UK life sciences.

Joint ABPI/BIA comment on EU Council Meeting

“We are now fewer than nine months away from the day the UK leaves the EU and as it stands we still do not have a deal on the future relationship or any certainty on the conditions our companies are expected to operate under come 29 March 2019...